Literature DB >> 1511442

Absence of p53 gene mutations in primary nasopharyngeal carcinomas.

C H Spruck1, Y C Tsai, D P Huang, A S Yang, W M Rideout, M Gonzalez-Zulueta, P Choi, K W Lo, M C Yu, P A Jones.   

Abstract

Alterations in the p53 tumor suppressor gene and Epstein-Barr virus status were investigated in 15 nasopharyngeal carcinoma (NPC) biopsies, 4 xenografts, and 2 cell lines from the Cantonese region of southern China. One other established NPC cell line obtained from a northern Chinese patient was also studied. Restriction fragment length polymorphism analysis revealed a loss of heterozygosity for chromosome 17p, where the p53 gene resides, in only one of 15 NPC biopsies. Polymerase chain reaction-single-stranded conformational polymorphism analysis and direct sequencing failed to detect sequence alterations in exons 5 through 8 of the p53 gene in the 15 tumors and in the 4 NPC xenografts, all of which tested positive for Epstein-Barr virus. In contrast, the 3 NPC cell lines were all negative for Epstein-Barr virus and contained G----C transversions in the p53 gene, with cell lines CNE-1 and CNE-2 harboring identical AGA (arginine) to ACA (threonine) changes at codon 280. These results suggest that p53 inactivation is not a necessary component of nasopharyngeal carcinogenesis in Cantonese but may be important in the establishment of cell lines derived from these tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1511442

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  Epstein-Barr virus and gastric carcinoma.

Authors:  K Takada
Journal:  Mol Pathol       Date:  2000-10

Review 2.  Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis.

Authors:  Javier S Burgos
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

3.  Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression.

Authors:  Shih-Shin Chang; You-Chang Lo; Huey-Huey Chua; Hsin-Yi Chiu; Shu-Chun Tsai; Jen-Yang Chen; Kwok-Wai Lo; Ching-Hwa Tsai
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

4.  Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.

Authors:  Laura R Wasil; Leizhen Wei; Christopher Chang; Li Lan; Kathy H Y Shair
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

5.  Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.

Authors:  Hong Zheng; Wei Dai; Arthur Kwok Leung Cheung; Josephine Mun Yee Ko; Rebecca Kan; Bonnie Wing Yan Wong; Merrin Man Long Leong; Mingdan Deng; Tommy Chin Tung Kwok; Jimmy Yu-Wai Chan; Dora Lai-Wan Kwong; Anne Wing-Mui Lee; Wai Tong Ng; Roger Kai Cheong Ngan; Chun Chung Yau; Stewart Tung; Victor Ho-Fun Lee; Ka-On Lam; Chung Kong Kwan; Wing Sum Li; Stephen Yau; Kwok-Wah Chan; Maria Li Lung
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

6.  BRD7 is a candidate tumour suppressor gene required for p53 function.

Authors:  Jarno Drost; Fiamma Mantovani; Francesca Tocco; Ran Elkon; Anna Comel; Henne Holstege; Ron Kerkhoven; Jos Jonkers; P Mathijs Voorhoeve; Reuven Agami; Giannino Del Sal
Journal:  Nat Cell Biol       Date:  2010-03-14       Impact factor: 28.824

7.  Expression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV encoded EBER1-2 transcripts and latent membrane protein-1.

Authors:  C Kouvidou; P Kanavaros; D Papaioannou; E Stathopoulos; F Sotsiou; G Datseris; M Tzardi; C Kittas; G Delides
Journal:  Clin Mol Pathol       Date:  1995-02

8.  MDM-2 protein expression in nasopharyngeal carcinomas. Comparative study with p53 protein expression.

Authors:  P Kanavaros; C Kouvidou; Y Dai; M Tzardi; G Datseris; K Darivianaki; D Rontogianni; G Delides
Journal:  Clin Mol Pathol       Date:  1995-12

9.  Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.

Authors:  Yock Ping Chow; Lu Ping Tan; San Jiun Chai; Norazlin Abdul Aziz; Siew Woh Choo; Paul Vey Hong Lim; Rajadurai Pathmanathan; Noor Kaslina Mohd Kornain; Chee Lun Lum; Kin Choo Pua; Yoke Yeow Yap; Tee Yong Tan; Soo Hwang Teo; Alan Soo-Beng Khoo; Vyomesh Patel
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

Review 10.  Locally advanced nasopharyngeal cancer.

Authors:  J F Ensley; E Youssef; H Kim; G Yoo
Journal:  Curr Treat Options Oncol       Date:  2001-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.